Literature DB >> 7015516

Rationale and proposal for use of prostacyclin in thrombotic thrombocytopenic purpura therapy.

D M Cocchetto, L Cook, A E Cato, J E Niedel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7015516     DOI： 10.1055/s-2007-1005069

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN： 0094-6176            Impact factor:   4.180


× No keyword cloud information.
  3 in total

Review 1.  Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin.

Authors:  S Moncada
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

2.  Prostacyclin (PGI2).

Authors:  S C Davies; S J Machin
Journal:  Intensive Care Med       Date:  1983       Impact factor: 17.440

3.  [Thrombotic thrombocytopenic purpura].

Authors:  C Aul; R E Scharf; T Königshausen; W Schneider
Journal:  Klin Wochenschr       Date:  1985-02-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.